Global CRO HEMEX chooses BSI Life Sciences’ eClinical platform for its clinical trial operations
BSI Life Sciences announces it has been awarded a SaaS agreement by global contract research organization HEMEX to provi…
BSI Life Sciences announces it has been awarded a SaaS agreement by global contract research organization HEMEX to provi…
BSI Life Sciences today announced biopharma Ocular Therapeutix (NASDAQ: OCUL) as its latest client to go live with its c…
BSI announces the adoption of its CTMS and eTMF solutions by CRO QbD Clinical, part of the QbD group. With 11 offices wo…
BSI announces Scimega as its first customer in Canada for its innovative software for clinical trials, BSI CTMS. Through…
BSI Life Sciences welcomes MEDIcept as a recent life science client in New England, US. Headquartered in Ashland, Massac…
Today, EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, announced the acquisition o…
EvidentIQ, the innovative provider of advanced clinical trial management solutions has joined forces with Quinta Analyti…
BSI Life Sciences announced the launch of BSI CTMS (Clinical Trial Management System) 7.0. The newest version of the eCl…
In early 2022 Mannheim-based CRO Advanced Medical Services (AMS) found itself at a crossroads after receiving news that…
Today, EvidentIQ, a leading clinical data science group and Keyrus Life Science, the Connected Contract Research Organiz…